Article info

Download PDFPDF
Natalizumab: safety and risk in patients with relapsing-remitting multiple sclerosis

Authors

  1. Correspondence to Belén Rodríguez de Castro, Hospital Universitario Cabueñes, Gijón 33394, Spain; b.rocas23{at}gmail.com
View Full Text

Citation

Rodríguez de Castro B, Barbosa CM, Ayastuy Ruiz A, et al
Natalizumab: safety and risk in patients with relapsing-remitting multiple sclerosis

Publication history

  • Received July 25, 2019
  • Revised October 2, 2019
  • Accepted October 7, 2019
  • First published October 16, 2019.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.